LL37
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LL37, covering 2021-12-09 to 2021-12-09. Get the full timeline:
Most recent: Clinical Trial Update: Intratumoral Injections of LL37 for Melanoma [Phase 1, Phase 2]